DURECT Corp
NASDAQ:DRRX

Watchlist Manager
DURECT Corp Logo
DURECT Corp
NASDAQ:DRRX
Watchlist
Price: 1.26 USD -2.33% Market Closed
Market Cap: 39.1m USD
Have any thoughts about
DURECT Corp?
Write Note

DURECT Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

DURECT Corp
Revenue Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
DURECT Corp
NASDAQ:DRRX
Revenue
$8.4m
CAGR 3-Years
0%
CAGR 5-Years
-13%
CAGR 10-Years
-7%
Johnson & Johnson
NYSE:JNJ
Revenue
$87.7B
CAGR 3-Years
-1%
CAGR 5-Years
1%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Revenue
$46.5B
CAGR 3-Years
2%
CAGR 5-Years
14%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Revenue
$55.6B
CAGR 3-Years
0%
CAGR 5-Years
10%
CAGR 10-Years
1%
Merck & Co Inc
NYSE:MRK
Revenue
$62.5B
CAGR 3-Years
12%
CAGR 5-Years
7%
CAGR 10-Years
4%
Eli Lilly and Co
NYSE:LLY
Revenue
$38.9B
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
6%

DURECT Corp
Revenue Breakdown

Breakdown by Geography
DURECT Corp

Total Revenue: 8.5m USD
100%
United States: 4.6m USD
54%
Europe: 2.3m USD
26.9%
Other Foreign Countries: 1.1m USD
12.5%
Japan: 559k USD
6.5%
Show More
Show Less

Breakdown by Segments
DURECT Corp

Total Revenue: 8.5m USD
100%
Product: 6.3m USD
73.4%
Collaborative Research And Development And Ot...: 2.3m USD
26.6%

See Also

What is DURECT Corp's Revenue?
Revenue
8.4m USD

Based on the financial report for Jun 30, 2024, DURECT Corp's Revenue amounts to 8.4m USD.

What is DURECT Corp's Revenue growth rate?
Revenue CAGR 10Y
-7%

Over the last year, the Revenue growth was -57%.

Back to Top